Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-05-06

Clinical Trial Update: TSO for Plaque Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating TSO for plaque psoriasis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TSO

Snippet

Sponsor: Coronado Biosciences, Inc. | Conditions: Plaque Psoriasis | Phase 2 | Status: WITHDRAWN